Welcome to our dedicated page for Resideo Technologies SEC filings (Ticker: REZI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Resideo Technologies, Inc. (NYSE: REZI) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a registrant with common stock listed on the New York Stock Exchange, Resideo submits current reports on Form 8‑K, annual reports on Form 10‑K, quarterly reports on Form 10‑Q, and other required documents that detail its financial condition, segment performance, capital structure, and material corporate events.
For a business that describes itself as a global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, these filings are a primary source of information on both the Products & Solutions and ADI Global Distribution segments. Investors can review how Resideo reports net revenue, gross margin, and segment income, as well as non‑GAAP measures such as Adjusted EBITDA that the company discusses in connection with its earnings releases. Forms 10‑K and 10‑Q typically provide segment breakdowns, risk factor discussions, and management’s analysis of operating trends.
Resideo’s Form 8‑K filings highlight material events and agreements, such as the Termination Agreement with Honeywell International Inc. to eliminate future monetary obligations under the Indemnification and Reimbursement Agreement, related credit agreement amendments and new term loans, and the announced intention to separate the ADI Global Distribution business through a tax-free spin-off. Other 8‑K filings describe executive appointments, amendments to executive agreements, shareholder voting results on compensation matters, and the release of quarterly earnings.
On Stock Titan, each new REZI filing is captured as it becomes available from EDGAR, and AI-powered summaries help explain the key points in accessible language. Users can quickly understand the implications of complex documents, from financing amendments and leverage covenant changes to governance updates and segment disclosures. In addition, investors interested in insider activity can monitor Form 4 beneficial ownership reports, while those researching compensation and governance can reference proxy materials when filed. This page is designed to make it easier to follow Resideo’s regulatory history and analyze how its sensing and controls, residential controls, and low-voltage distribution businesses are reflected in its official SEC reporting.
Insider exercise and share withholding by Resideo executive. Stephen M. Kelly, EVP and Chief HR Officer of Resideo Technologies (REZI), reported option activity on 08/12/2025. He exercised fully vested stock options with a $24.39 exercise price for 38,053 shares; the filing shows those options were exercisable through 02/10/2026. To satisfy the exercise price and tax withholding, the issuer withheld 32,970 shares at an implied price of $31.28. After these transactions the report lists 233,289 shares beneficially owned by Mr. Kelly (direct ownership). The option grant that produced the exercised shares is described as fully vested, and the Form 4 was signed by an attorney-in-fact on 08/14/2025.
Jeannine J. Lane, Resideo Technologies (REZI) EVP, General Counsel and Corporate Secretary, reported option exercise and contemporaneous sale on 08/12/2025. The filing shows Lane exercised a stock option with a $24.39 exercise price for 35,398 shares and immediately sold 35,398 shares at a weighted average price of $31.312. After these transactions, the filing reports Lane beneficially owned 155,136 shares (down from 190,534 before the sale); the prior balance included 352 shares that were omitted in earlier Form 4s. The Form notes the option was fully vested and provides the sale price range of $31.31 to $31.345.
Resideo Technologies completed a transaction that terminated a long‑standing indemnification and reimbursement arrangement with Honeywell in exchange for a one‑time $1,590,000,000 cash payment. The termination eliminated Resideo’s obligation to make annual payments to Honeywell of up to $140 million through year‑end 2043 and removed the affirmative and negative covenants under that agreement, subject only to limited provisions that survived termination.
To fund part of the payment, Resideo amended its existing credit facilities and obtained incremental senior secured term loans totaling $1.225 billion with a seven‑year maturity and interest at Term SOFR plus 2.00%. The amendment also raised the interest on certain existing term B tranches from Term SOFR plus 1.75% to Term SOFR plus 2.00%, increased capacity to incur incremental debt, temporarily relaxed the total leverage covenant to 4.00:1.00 for two upcoming test periods, and permits future revolver refinancings.
Resideo Technologies insider transaction summary The Form 4 reports that CD&R-affiliated entities, identified as a director and greater-than-10% owner, purchased a total of 1,246,123 shares of Resideo Technologies, Inc. (REZI) across transactions dated 08/08/2025, 08/11/2025 and 08/12/2025. The filing shows weighted-average prices for the five reported lots of $27.3003, $27.3366, $30.0345, $30.9423 and $31.4902, and footnotes disclose the price ranges for each lot.
Following these purchases the reporting persons' disclosed beneficial ownership rose to 11,478,543 shares. The securities are owned directly by CD&R Channel Holdings II, L.P., with CD&R Investment Associates XII, Ltd. and CD&R Associates XII, L.P. identified as affiliated entities that may be deemed to beneficially own the reported securities.
Resideo Technologies insider filing: Michael Carlet, the company's Chief Financial Officer, reported a purchase of 1,540 shares of Resideo Technologies, Inc. (REZI) on 08/09/2025 at a reported price of $27.37 per share. Following the transaction his beneficial ownership is reported as 160,861 shares. The transaction is recorded on a Form 4 and is shown with transaction code F.
Resideo Technologies, Inc. filed a Form 144 reporting a proposed sale of 35,398 common shares through Morgan Stanley Smith Barney on 08/12/2025. The filing lists an aggregate market value of $1,108,378.64 against 148,763,403 shares outstanding, and names the NYSE as the exchange. The notice shows the shares were acquired by a stock option exercise on 08/12/2025 and payment was made in cash.
The filer indicates there were no securities sold by the person in the past three months. Other identifying details for the filer and the issuer (such as specific names or relationship descriptions) are not provided in the text of this filing. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Resideo Technologies (REZI) filed a Form 144 disclosing a proposed sale of 47,500 shares of common stock, with an aggregate market value of $1,486,279.75, to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/12/2025. The filing shows total shares outstanding of 148,763,403, and states there were no securities sold in the past three months by the selling person.
The securities offered were received as restricted stock in three lots dated 02/18/2023 (19,446 shares), 02/18/2024 (2,592 shares) and 02/09/2025 (25,462 shares). The filer affirms they are not aware of any undisclosed material adverse information about the issuer.
Boston Partners filed a Schedule 13G/A reporting beneficial ownership of Resideo Technologies common stock. The firm reports ownership of 8,394,667 shares, representing 5.65% of the outstanding class, and may be deemed a beneficial owner under the Exchange Act.
The filing shows Boston Partners has sole voting power over 6,669,489 shares and sole dispositive power over 8,394,667 shares. The shares are held in discretionary client accounts and the filer certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.